MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2176/nmc.cr.2016-0330

Медицинская библиотека · Neurologia medico-chirurgica · 2017

Immunotherapy of Nivolumab with Dendritic Cell Vaccination Is Effective against Intractable Recurrent Primary Central Nervous System Lymphoma: A Case Report.

Furuse Motomasa, Nonoguchi Naosuke, Omura Naoki, Shirahata Mitsuaki, Iwasaki Koichi, Inui Toshio, Kuroiwa Toshihiko, Kuwabara Hiroko, Miyatake Shin-Ichi

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

We report effective treatment with nivolumab of a patient with recurrent primary central nervous system lymphoma (PCNSL) after multiple therapies. A 41-year-old woman with a right parietal PCNSL underwent treatment with high-dose methotrexate and radiotherapy. After recurrence in the left frontal lobe, the patient received several chemotherapies, including methotrexate and rituximab, and underwent surgery. The tumor was refractory to these treatments, and the patient then underwent intensity-modulated radiotherapy (IMRT). Multiple small, new recurrent tumors appeared in the right frontal lobe and the left frontoparietal region 2 months after IMRT. The patient received nivolumab 3 mg/kg with dendritic cell vaccination. Complete remission of the tumors was achieved after six cycles of nivolumab, and remission was maintained for 10 months after the initiation of nivolumab. Nivolumab could be a novel treatment for intractable recurrent PCNSL in the future.

Для цитирования: Furuse Motomasa, Nonoguchi Naosuke, Omura Naoki, Shirahata Mitsuaki, Iwasaki Koichi, Inui Toshio, Kuroiwa Toshihiko, Kuwabara Hiroko, Miyatake Shin-Ichi. Immunotherapy of Nivolumab with Dendritic Cell Vaccination Is Effective against Intractable Recurrent Primary Central Nervous System Lymphoma: A Case Report.. Neurologia medico-chirurgica. 2017. DOI: 10.2176/nmc.cr.2016-0330.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.